Could a Risk-Based screening schedule replace standard mammograms?
NCT ID NCT06060938
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study involves 2,200 women aged 50–67 to see if personalized mammography screening, based on genetic and lifestyle risk factors, is safe and acceptable. Half the women receive standard biennial mammograms, while the other half get a risk assessment and a tailored screening schedule (every 1–4 years). The main goal is to measure how many low-risk women choose to stick with the standard 2-year interval instead of the recommended 4-year interval.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dept. of Breast Examinations, Herlev Gentofte Hospital, Copenhagen University Hospital
Gentofte Municipality, 2900, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?